Obesity phenotypes, including MUHO and metabolically healthy obesity (MHO), were classified based on the Joint Interim Statement criteria for metabolic syndrome [95], which rely on clinical and biochemical cardiometabolic risk markers rather than insulin resistance or inflammatory profiles. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.